View |
|
DRP-7552-01
|
Bisacodyl
|
None
|
5 mg
|
Delayed-Release Tablet
|
Contact Laxative
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
30 December 2022
|
31 March 2026
|
View |
|
BRP-063-02
|
Enoxaparin Sodium
|
Carcenoxar
|
2,000 IU Anti-Factor Xa (equivalent to 20 mg)/0.2 mL
|
Solution for Injection (IV/SC)
|
Antithrombotic Agent
|
Brawn Laboratories Limited
|
India
|
Renewal
|
12 June 2023
|
15 August 2026
|
View |
|
DRP-5548-01
|
Glimepiride
|
Unbranded
|
4 mg
|
Tablet
|
Oral Hypoglycemic Agent
|
Zim Laboratories Ltd.
|
India
|
Renewal
|
19 June 2024
|
01 October 2029
|
View |
|
DRP-4815-04
|
Lactulose
|
Zerrilose
|
3.35g/5 mL
|
Syrup
|
Osmotic Laxative
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
27 December 2022
|
10 February 2027
|
View |
|
DRP-5082-04
|
Paracetamol + Tramadol Hydrochloride
|
Belcetra
|
325 mg/ 37.5 mg
|
Film-Coated Tablet
|
Antipyretic/ Opioid Analgesic
|
Samchundang Pharm. Co. Ltd
|
Korea
|
Renewal
|
31 January 2024
|
28 February 2029
|
View |
|
BRP-065-03
|
Insulin Human (rDNA)
|
Insuljack N
|
100 IU/mL
|
Suspension for Injection (IM/SC) (100% Isophane Insulin Human)
|
Antidiabetics
|
M.J. Biopharm Pvt., Ltd
|
India
|
CLIDP Conversion
|
26 December 2022
|
28 August 2026
|
View |
|
BRP-074-03
|
Insulin Human (rDNA)
|
Insuljack 30:70
|
100 IU/mL
|
Suspension for Injection (IM/SC) (30% Soluble Insulin Human/ 70% Isophane Insulin Human)
|
Antidiabetic Agents
|
M.J. Biopharm Pvt., Ltd.
|
India
|
CLIDP Conversion
|
26 December 2022
|
23 February 2027
|
View |
|
DRP-5985-03
|
Domperidone
|
Zerridone
|
1 mg / mL
|
Suspension
|
Propulsives
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
26 December 2022
|
11 November 2026
|
View |
|
DRP-12901-01
|
Amlodipine (as besilate)
|
Philvasc
|
10mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
26 December 2022
|
27 October 2027
|
View |
|
DRP-771-13
|
Multivitamins + Iron + Folic Acid
|
Folironplex
|
Ferrous Sulfate (equivalent to 60 mg elemental Iron) 200 mg, Thiamine Mononitrate (Vitamin B1) 10 mg, Riboflavin (Vitamin B2) 5 mg, Pyridoxine HCl (Vitamin B6) 5 mg, Cyanocobalamin (Vitamin B12) 20 mcg, Folic Acid 400 mcg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
23 December 2022
|
08 November 2027
|
View |
|
DRP-4489-05
|
Telmisartan + Hydrochlorothiazide
|
Telxibloc
|
40 mg/12.5 mg
|
Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
23 December 2022
|
18 June 2028
|
View |
|
DRP-5488-04
|
Etoricoxib
|
Akticib
|
120 mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Zim Laboratories Ltd.
|
India
|
Renewal
|
22 March 2024
|
27 August 2029
|
View |
|
DRP-5926-05
|
Cefixime (as Trihydrate)
|
Zelixime
|
100 mg / 5 mL
|
Powder for Suspension
|
-
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
23 December 2022
|
12 October 2026
|
View |
|
DRP-7734-04
|
Dexamethasone + Neomycin (as sulfate) + Polymyxin-BSulfate
|
None
|
1 mg/ 3.5 mg/ 6000 I.U
|
Ophthalmic & Otic Suspension
|
-
|
Egyptian International Pharmaceutical Industries Co.
|
Egypt
|
CLIDP Conversion
|
23 December 2022
|
16 March 2028
|
View |
|
DRP-4649-03
|
Glimepiride
|
Glyperide
|
2 mg
|
Tablet
|
Blood Glucose-Lowering Drug (Sulfonylurea)
|
LifeSquare Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
23 December 2022
|
06 September 2025
|
View |
DRP-7359-12_PI_01.pdf
|
DRP-7359-12
|
Spironolactone
|
Aldax
|
25 mg
|
Tablet
|
Diuretic
|
Maxtar Bio-Genics
|
India
|
CLIDP Conversion
|
22 January 2023
|
04 October 2026
|
View |
DRP-8043-03_PI_01.pdf
|
DRP-8043-03
|
Montelukast (as Sodium)
|
Aerokids
|
4 mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Glenmark Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
22 December 2022
|
21 November 2026
|
View |
|
BRP-119
|
Human Chorionic Gonadotrophin
|
Pubergen
|
5000 IU
|
Lyophilized Powder for Injection (IM)
|
-
|
Sanzyme (P) Ltd.
|
India
|
PCPR Conversion
|
30 December 2022
|
11 April 2027
|
View |
|
BRP-118
|
Menotrophin
|
Gynogen HP
|
75 IU
|
Lyophilized Powder for Solution for Injection
|
-
|
Sanzyme (P) Ltd.
|
India
|
PCPR Conversion
|
30 December 2022
|
11 April 2027
|
View |
|
BRP-117
|
Urofollitropin
|
Endogen HP
|
75 IU
|
Lyophilized Powder for Solution for Injection
|
-
|
Sanzyme (P) Ltd.
|
India
|
PCPR Conversion
|
30 January 2023
|
11 April 2027
|